24 completed, 19 recruiting, 14 not yet recruiting, 2 terminated. 31 Not applicable, 11 Phase 4, 5 Phase 2, 2 Phase 3.
Follow Overactive Bladder (OAB): new trials by email Literature Review of Overactive Bladder (OAB) trials Research Report on Overactive Bladder (OAB)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Peroneal Neuromodulation vs Pelvic Floor Exercises in OAB Transcutaneous Peroneal Electrical Neuromodulation, Pelvic Floor Exercise - Overactive Bladder (OAB), Neuromodulation | Not applicable | Not yet recruiting | Marmara University | 60 | 2026-12-01 | 2026-08-26 |
| Long-Term Effectiveness and Safety of Sacral Neuromodulation With InterStim for Lower Urinary Tract Dysfunction InterStim™ Sacral Neuromodulation System II - X - Overactive Bladder (OAB), Urgency Urinary Incontinence | Not yet recruiting | Fundación Santa Fe de Bogota | 1700 | 2026-12-01 | 2026-10-02 | |
| Predictive Value of Inflammatory Biomarkers for Mirabegron Response in Women With Overactive Bladder Mirabegron (beta3-adrenoceptor agonist) - Overactive Bladder (OAB) | Not yet recruiting | Bagcilar Training and Research Hospital | 115 | 2026-11-01 | 2026-10-05 | |
| Impact of Transcutaneous Electrical Nerve Stimulation on the Autonomic Nervous System in the Treatment of Overactive Bladder heart rate variability assement - Overactive Bladder (OAB) | Not applicable | Not yet recruiting | Centre Hospitalier de Roubaix | 70 | 2026-10-01 | 2026-08-24 |
| Parasacral TENS Project Parasacral transcutaneous electric nerve stimulation (TENS), Oxybutynin - Overactive Bladder (OAB), Lower Urinary Tract Dysfunction | Not applicable | Not yet recruiting | University of Virginia | 60 | 2026-09-30 | 2026-10-23 |
| Non-invasive Saphenous Nerve Stimulation Therapy for Overactive Bladder Wearable neurostimulation system for saphenous nerve stimulation, tolterodine tartrate 4 mg extended release - Overactive Bladder (OAB) | Phase 3 | Not yet recruiting | NinaMED Pty Ltd | 290 | 2026-09-10 | 2026-08-24 |
| Efficacy of Transcutaneous Electrical Stimulation Therapy in the Treatment of Overactive Bladder Developing After Stroke posterior tibial nerve stimulation, PTNS - Stroke, Overactive Bladder (OAB) | Not applicable | Not yet recruiting | Kutahya Health Sciences University | 50 | 2026-09-01 | 2026-07-31 |
| Effectiveness of Ambulatory Transcutaneous Tibial Nerve Stimulation for Overactive Bladder Ambulatory Transcutaneous Tibial Nerve Stimulation, Conventional Clinic-Based Transcutaneous Tibial Nerve Stimulation - Overactive Bladder (OAB), Urinary Urgency | Not applicable | Recruiting | SEZGIN | 60 | 2026-08-15 | 2026-09-18 |
| RELIEVE Study: NT 201 Intravesical Administration Using Vibe System (ViXe Combination Product) for the Treatment of Idiopathic Overactive Bladder NT 201 200U and Vibe System, NT 201 300U and Vibe System, Placebo and sham - Overactive Bladder (OAB) | Phase 2 | Recruiting | Vensica Therapeutics Ltd. | 210 | 2026-08-14 | 2026-10-16 |
| Pretibial TENS for Pain and Anxiety During Intravesical OnabotulinumtoxinA Injection Active Pretibial TENS, Sham Pretibial TENS - Overactive Bladder (OAB), Botulinum Toxin Injection | Not applicable | Not yet recruiting | Başakşehir Çam & Sakura City Hospital | 68 | 2026-07-20 | 2026-07-16 |
| Burden and Efficacy of Anticholinergic vs Mirabegron in Overactive Bladder - A Randomized Controlled Study Solifencin, Mirabegron - Overactive Bladder (OAB) | Phase 4 | Not yet recruiting | Universidade do Porto | 208 | 2026-07-01 | 2026-07-17 |
| Efficacy of Probiotics for OAB Patients With Anxiety Multi-strain Probiotic Compound, Placebo - Overactive Bladder (OAB) | Not applicable | Not yet recruiting | Qilu Hospital of Shandong University | 218 | 2026-07-01 | 2026-06-09 |
| Real-world Experiences and Voices Exploring the Actual Lived Burden of OAB: A Mixed-methods Multi-country PROMs Study on OAB Patients' Quality of Life Overactive Bladder (OAB), Overactive Bladder Syndrome | Not yet recruiting | European Association of Urology Research Foundation | 2000 | 2026-07-01 | 2026-05-06 | |
| A Novel Wearable Transcutaneous Tibial Nerve Stimulation (TTNS) Device in the Treatment of Patients With Overactive Bladder (OAB) and Nocturia A new wearable transcutaneous tibial nerve stimulation (TTNS) device, behavioral therapy - Overactive Bladder (OAB), Nocturia | Not applicable | Not yet recruiting | Qilu Hospital of Shandong University | 80 | 2026-06-10 | 2026-06-09 |
| Tensi+ for Treating Overactive Bladder Tensi+ - Overactive Bladder (OAB) | Not applicable | Recruiting | Stimuli Technology | 60 | 2026-05-26 | 2026-09-11 |
| Aquarius Pilot Study to Evaluate the New Axonics Trial System Axonics External Trial System (ETS) - Urinary Urge Incontinence (UUI), Urinary Frequency (UF) | Not applicable | Recruiting | Axonics, Inc. | 75 | 2026-04-30 | 2026-10-13 |
| INOPASE - Performance and Safety Study of a Personalised SNM System Sacral Neuromodulation System - Overactive Bladder (OAB) | Not applicable | Recruiting | INOPASE Pty Ltd | 10 | 2026-02-27 | 2026-05-18 |
| Zinc Supplementation With Botulinum Toxin for Overactive Bladder Zinc Citrate Oral Capsule, Placebo - Overactive Bladder (OAB) | Phase 2 | Recruiting | Endeavor Health | 72 | 2026-02-26 | 2026-07-02 |
| Evaluate the Safety and Efficacy of TRG-200 KIT in Patients With Refractory Overactive Bladder. TRG-200 KIT - Overactive Bladder (OAB) | Phase 2 | Not yet recruiting | Trigone Pharma Ltd. | 60 | 2026-02-15 | 2026-02-06 |
| Cefar URO - Symptomatic Treatment of Overactive Bladder Transcutaneous Tibial Nerve Stimulation (TTNS) with the Cefar Uro Device - Overactive Bladder (OAB), Refractory Overactive Bladder | Not applicable | Recruiting | DJO UK Ltd | 53 | 2026-01-19 | 2026-08-28 |
Showing 20 of 62. Sign in to see all of them.
Urinary Bladder, Overactive (62) · Urinary Incontinence, Urge (11) · Lower Urinary Tract Symptoms (2) · Nocturia (2) · Urinary Incontinence (2) · Alzheimer Disease (1) · Anxiety Disorders (1) · Disease (1) · Fecal Incontinence (1) · Inflammation (1) · Motor Activity (1) · Pain, Procedural (1) · Premature Birth (1) · Stroke (1) · Urinary Retention (1)
Female Urogenital Diseases (62) · Female Urogenital Diseases and Pregnancy Complications (62) · Male Urogenital Diseases (62) · Pathological Conditions, Signs and Symptoms (62) · Signs and Symptoms (62) · Urinary Bladder Diseases (62) · Urogenital Diseases (62) · Urologic Diseases (62) · Urological Manifestations (62) · Lower Urinary Tract Symptoms (60) · Urination Disorders (13) · Urinary Incontinence (11) · Brain Diseases (2) · Central Nervous System Diseases (2) · Mental Disorders (2)
mirabegron (11) · Tolterodine Tartrate (7) · Solifenacin Succinate (6) · oxybutynin (5) · Botulinum Toxins, Type A (3) · darifenacin (3) · fesoterodine (3) · imidafenacin (3) · Transcutaneous Electric Nerve Stimulation (2) · propiverine (2) · trospium chloride (2) · Anti-Bacterial Agents (1) · Behavior Therapy (1) · Cholinergic Antagonists (1) · Estradiol (1)
Astellas Pharma Global Development, Inc. (3) · Astellas Pharma Singapore Pte. Ltd. (3) · Astellas Pharma Inc (2) · Axonics, Inc. (2) · Başakşehir Çam & Sakura City Hospital (2) · FemPulse Corporation (2) · Mansoura University (2) · Marmara University (2) · Medstar Health Research Institute (2) · Qilu Hospital of Shandong University (2) · Alexis Dieter (1) · Astellas Pharma China, Inc. (1) · Astellas Pharma Europe Ltd. (1) · Bagcilar Training and Research Hospital (1) · Birmingham Women's and Children's NHS Foundation Trust (1)
United States (18) · Turkey (Türkiye) (11) · Australia (5) · South Korea (5) · Canada (4) · China (4) · United Kingdom (4) · France (3) · Taiwan (3) · Czechia (2) · Egypt (2) · Ireland (2) · Italy (2) · Japan (2) · Norway (2)
Ahmed A Shokeir, professor of urology (1) · Ahmet H Sevinc, MD, Urology Specialist (1) · Ailsa Wilson Edwards, MD (1) · Eamonn T. Rogers, M Ch M Med Sci FRCSI FRCS(Urol (1) · Ghazaleh Rostami Nia, MD (1) · Gita Ghadimi, OD (1) · Gokay Ozceltik, Associate Professor (1) · Guillaume Carnaux, physiotherapist specialized in (1)
PMID 10767443, PMID 14662404, PMID 18811599, PMID 19070418, PMID 20860020, PMID 22741748, PMID 30971304, PMID 32183741, PMID 32295114, PMID 32725584, PMID 33429090, PMID 33918217, PMID 34565565, PMID 34906515, PMID 37148497, PMID 38430402, PMID 40724784, PMID 40731828, PMID 41097836
2016 (1)